Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Autor: Agathangelidis, A. Chatzidimitriou, A. Gemenetzi, K. Giudicelli, V. Karypidou, M. Plevova, K. Davis, Z. Yan, X.-J. Jeromin, S. Schneider, C. Pedersen, L.B. Tschumper, R.C. Sutton, L.-A. Baliakas, P. Scarfò, L. van Gastel, E.J. Armand, M. Tausch, E. Biderman, B. Baer, C. Bagnara, D. Navarro, A. Langlois de Septenville, A. Guido, V. Mitterbauer-Hohendanner, G. Dimovski, A. Brieghel, C. Lawless, S. Meggendorfer, M. Brazdilova, K. Ritgen, M. Facco, M. Tresoldi, C. Visentin, A. Patriarca, A. Catherwood, M. Bonello, L. Sudarikov, A. Vanura, K. Roumelioti, M. Skuhrova Francova, H. Moysiadis, T. Veronese, S. Giannopoulos, K. Mansouri, L. Karan-Djurasevic, T. Sandaltzopoulos, R. Bödör, C. Fais, F. Kater, A. Panovska, I. Rossi, D. Alshemmari, S. Panagiotidis, P. Costeas, P. Espinet, B. Antic, D. Foroni, L. Montillo, M. Trentin, L. Stavroyianni, N. Gaidano, G. Francia di Celle, P. Niemann, C. Campo, E. Anagnostopoulos, A. Pott, C. Fischer, K. Hallek, M. Oscier, D. Stilgenbauer, S. Haferlach, C. Jelinek, D. Chiorazzi, N. Pospisilova, S. Lefranc, M.-P. Kossida, S. Langerak, A.W. Belessi, C. Davi, F. Rosenquist, R. Ghia, P. Stamatopoulos, K. ERIC, the European Research Initiative on CLL

Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::02389fc31ced158666879616aa7abc06
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2999928

Impacts of COVID-19 local spread and Google search trend on the US stock market.

Autor: Dey AK; Department of Mathematical Sciences, University of Texas at El Paso, El Paso, TX 79968, USA.; Department of Electrical and & Computer Engineering, Princeton University, Princeton, NJ 08544, USA., Hoque GMT; Department of Mathematics, Lamar University, Beaumont, TX 77705, USA., Das KP; The Office of Vice President for Research, Innovation, and Economic Development, University of Louisiana at Lafayette, Lafayette, LA 70504, USA., Panovska I; School of Economic, Political, and Policy Sciences, University of Texas at Dallas, Richardson, TX 75080, USA.

Publikováno v: Physica A [Physica A] 2022 Mar 01; Vol. 589, pp. 126423. Date of Electronic Publication: 2021 Sep 30.

Oftalmopatia Bilateralis as unusual Presentation of a Long Term Localized Hodgkin,s Lymphoma

Autor: Panovska, I, Hadzi-Pecova, L, Stojanovski, Z, Grueva, L, Tosev, S, Popova, M

Oftalmopatia Bilateralis as unusual Presentation of a Long Term Localized Hodgkin's Lymphoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::c4bb3379b082ecfcc68ff44b1b705458
https://www.bib.irb.hr/1131764

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

Autor: Agathangelidis A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Chatzidimitriou A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Gemenetzi K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece., Giudicelli V; International ImMunoGeneTics Information System (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (IGH), Unité Mixte de Recherche (UMR), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier, Montpellier, France., Karypidou M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Plevova K; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Yan XJ; The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY., Jeromin S; MLL Munich Leukemia Laboratory, Munich, Germany., Schneider C; University Hospital Medical Center, Ulm, Germany., Pedersen LB; Deparment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Tschumper RC; Department of Immunology, Mayo Clinic, Rochester, MN., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Baliakas P; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Scarfò L; Strategic Research Program on CLL, B-Cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele/Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy., van Gastel EJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center (UMC), Rotterdam, The Netherlands., Armand M; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Department of Biological Hematology, Sorbonne Université, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Biderman B; National Research Center for Hematology, Moscow, Russia., Baer C; MLL Munich Leukemia Laboratory, Munich, Germany., Bagnara D; Department of Experimental Medicine, University of Genoa, Genoa, Italy., Navarro A; Centro de Investigacion Biomedica en Red en Oncologia (CIBERONC), Madrid, Spain.; Institut d'Investigacions Biomediques August Pi I Sunyer, Barcelona, Spain., Langlois de Septenville A; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Department of Biological Hematology, Sorbonne Université, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France., Guido V; Molecular Pathology Unit, Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Mitterbauer-Hohendanner G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Dimovski A; Faculty of Pharmacy, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Northern Macedonia., Brieghel C; Deparment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Lawless S; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Brazdilova K; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Ritgen M; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Facco M; Hematology and Clinical Immunology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Tresoldi C; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Patriarca A; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont-Ospedale Maggiore della Carità, Novara, Italy., Catherwood M; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom., Bonello L; General Anatomopathology and Molecular Oncogenetics, Azienda Ospedaliero Universitaria (AOU), City of Health and Science of Turin, Turin, Italy., Sudarikov A; National Research Center for Hematology, Moscow, Russia., Vanura K; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Roumelioti M; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece., Skuhrova Francova H; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic., Moysiadis T; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Veronese S; Molecular Pathology Unit, Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Giannopoulos K; Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland., Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Karan-Djurasevic T; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Sandaltzopoulos R; Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece., Bödör C; MTA-SE Momentum Molecular Oncohematology Research Group, First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Fais F; Department of Experimental Medicine, University of Genoa, Genoa, Italy.; UO Molecular Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Kater AP; Department of Hematology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC-University of Amsterdam, Amsterdam, The Netherlands., Panovska I; Department of Hematology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Northern Macedonia., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Alshemmari S; Department of Medicine, Faculty of Medicine, Kuwait University, Safat, Kuwait., Panagiotidis P; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece., Costeas P; The Center for the Study of Haematological Malignancies, Nicosia, Cyprus.; Karaiskakio Foundation, Nicosia, Cyprus., Espinet B; Laboratorio de Citogenètica Molecular, Laboratori de Citologia Hematològica, Servei de Patologia i Servei de Hematologia, Hospital del Mar, Barcelona, Spain., Antic D; Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia., Foroni L; Hammersmith Hospital, London, United Kingdom., Montillo M; Molecular Pathology Unit, Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Trentin L; Hematology and Clinical Immunology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Stavroyianni N; Hematocrit (HCT) Unit, Hematology Department, G. Papanicolaou Hospital, Thessaloniki, Greece., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont-Ospedale Maggiore della Carità, Novara, Italy., Francia di Celle P; General Anatomopathology and Molecular Oncogenetics, Azienda Ospedaliero Universitaria (AOU), City of Health and Science of Turin, Turin, Italy., Niemann C; Deparment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Campo E; Centro de Investigacion Biomedica en Red en Oncologia (CIBERONC), Madrid, Spain.; Institut d'Investigacions Biomediques August Pi I Sunyer, Barcelona, Spain.; Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Anagnostopoulos A; Hammersmith Hospital, London, United Kingdom., Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Fischer K; University Hospital Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Jelinek D; Department of Immunology, Mayo Clinic, Scottsdale, AZ., Chiorazzi N; The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY., Pospisilova S; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Lefranc MP; International ImMunoGeneTics Information System (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (IGH), Unité Mixte de Recherche (UMR), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier, Montpellier, France., Kossida S; International ImMunoGeneTics Information System (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (IGH), Unité Mixte de Recherche (UMR), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier, Montpellier, France., Langerak AW; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center (UMC), Rotterdam, The Netherlands., Belessi C; Hematology Department, Nikea General Hospital, Pireaus, Greece; and., Davi F; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center (UMC), Rotterdam, The Netherlands., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden., Ghia P; Strategic Research Program on CLL, B-Cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele/Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy., Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

Publikováno v: Blood [Blood] 2021 Mar 11; Vol. 137 (10), pp. 1365-1376.